Agoracom Blog Home

Posts Tagged ‘Marijuana’

« Older Entries
Newer Entries »

North Bud Farms Fuels California Growth $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:23 PM on Wednesday, April 15th, 2020
  • Fueled its California growth with the execution of definitive agreements for a master lease, operations and royalty arrangement with an experienced California-licensed operator
  • To operate the licensed facilities at the Company’s Salinas, California farm
  • Significantly strengthens the Company’s facility operations while allowing the Company to increase its asset value

TORONTO, April 15, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce that its U.S. subsidiary, Bonfire Brands USA Inc., has fueled its California growth with the execution of definitive agreements (the “Agreements”) for a master lease, operations and royalty arrangement with an experienced California-licensed operator (the “Cultivator”), to operate the licensed facilities at the Company’s Salinas, California farm.

Highlights of the California Deal

  • Partnering with a proven licensed cannabis cultivator who has been operating successfully in Salinas for several years;
  • Significantly strengthens the Company’s facility operations while allowing the Company to increase its asset value;
  • Reduces the Company’s capital expenditure requirements while still generating significant revenue and retaining a portion of the unlimited upside potential through a royalty agreement;
  • Builds EBITDA-positive operations; and
  • Access to a cost-efficient and reliable supply chain on which to build the Company’s branded product portfolio within the state of California.

Terms of the Agreement
As per the terms of the Agreements, the Cultivator will lease the Company’s Salinas farm for 5 years, with options to extend the lease for up to an additional 5 years, and Bonfire Brands USA Inc. will receive the following consideration:

  • Lease payments of USD$900,000 per year, with incremental increases if the Cultivator extends the lease beyond the initial 5 year term;
  • A royalty equal to 5% of the gross revenue generated by the Cultivator from its use of the Salinas farm; and
  • The right to acquire a significant portion of the product harvested each quarter on the farm by the Cultivator, at a 15% discount to market rate.

During the term of the Agreements, the Cultivator will be responsible for the costs of operating the farm, including but not limited to staffing, operations, repair, maintenance, licensing and compliance; moreover, the Cultivator is committed to funding and managing the build-out of up to an additional 230,000 sq. ft. of licensed cultivation space in order to maximize the revenue-generating potential of the property.

“We are very pleased to have concluded this deal as we partner with an established operator to build up our asset and to secure access to high-quality, low-cost cannabis,” said Justin Braune, President of Bonfire Brands USA. “This deal will allow the Company to immediately achieve EBITDA-positive operations at our largest facility without incurring significant capital investments. By retaining preferential purchasing terms, the Company can now focus on the success of its branded product lines, on the back of the estimated 40,000 pounds of production capacity that the Cultivator is expected to bring online over the next 24 months.”

About North Bud Farms Inc.
NORTHBUD owns and operates, through its subsidiaries, licensed cannabis facilities in Canada, California and Nevada. Bonfire Brands USA, the Company’s U.S. subsidiary, acquired cannabis production facilities in Salinas, California and Reno, Nevada in late 2019. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada facility, located on 3.2 acres of land, was acquired through the acquisition of Nevada Botanical Science, Inc., and includes a world-class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation space which holds medical and adult-use licenses for cultivation, extraction and distribution. Through its wholly-owned Canadian subsidiary, GrowPros MMP Inc., the Company built and owns a state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada. The Low, Quebec facility currently has 24,500 sq. ft. of licensed indoor cultivation space; the Company expects to submit its licence application to Health Canada for an additional 1,000,000 sq. ft. of outdoor cultivation space in the near future.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including but not limited to, the success of its arrangement with the Cultivator to lease and operate its Salinas farm, U.S. and Canadian strategies, the success of the Company’s licence application with Health Canada, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]           

Tags: , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on North Bud Farms Fuels California Growth $CGC $ACB $APH $CRON.ca $OGI.ca

With greater acceptance and understanding, people know more than ever about #CBD – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 3:55 PM on Wednesday, April 15th, 2020

SPONSOR: Hollister Biosciences Inc. (HOLL:CSE) A vertically integrated cannabis company with products in 220 California dispensaries and joint ventures, licensing agreement & partnerships with global brands. The company recently closed $20 MILLION deal with Venom Extracts adding $CDN 16.4 million in revenue and $CDN 2.48 million in EBITDA. Learn More

With greater acceptance and understanding, people know more than ever about CBD. But did you know these five fascinating facts?

  • As research continues to grow, so too does the demand for CBD products
  • So much so, in fact, that the market has yielded some impressive profits in the two years since the Farm Bill was passed; which effectively legalised hemp and CBD at the federal level

By: Michael Turner

With all the hype surrounding CBD, there’s plenty of information to be had on the compound. Derived from hemp, CBD is one of 113 cannabinoids found in cannabis. Each cannabinoid interacts with our body in a specific way, and we even have specialised receptors in our nervous system to accept them.

As research continues to grow, so too does the demand for CBD products. So much so, in fact, that the market has yielded some impressive profits in the two years since the Farm Bill was passed; which effectively legalised hemp and CBD at the federal level.

Whatever you might know about CBD, there’s a good chance you don’t know these five facts. Keep reading to learn what they are, they might just surprise you.

1. It’s One Of The Fastest-Growing Industries In History: You can buy pharmaceutical grade CBD oil in stores and at several online providers all over the country. This massive spread of CBD products is due to the incredible demand for CBD and CBD-based products; causing the industry to become one of the fastest-growing in history.

Financial experts have predicted that the CBD industry has grown at around 107% per-year, and will continue to do so for the better half of the decade. People simply love CBD products, and as researchers discover more amazing benefits, the demand only grows.

The CBD industry managed to surpass the one billion dollar mark last year, and is projected to surpass 10-20 billion in the next few years. As misinformation and stigma dissipate, facts and scientific data take their place, making cannabis, hemp, and CBD better understood by everyone.

2. It Can Help Cancer Patients Manage Symptoms: CBD offers some very promising results in cancer patients. Cancer is a devastating condition where cells divide uncontrollably and destroy tissue. This can include muscle tissue, organs, blood vessels, and more. Often, cancer is incredibly painful, and the treatments available for cancer are no less uncomfortable than the disease itself.

Cannabinoids may actually help with more than just the symptoms of cancer, however. Certain studies have shown that cannabinoids, including CBD, might actually help to slow the growth of tumours. Another study found that it could potentially make cancerous cells more susceptible to radiation while not affecting healthy cells.

Overall, it would seem that CBD has the ability to inhibit cancer growth, manage symptoms, and aid in the destruction of cancerous cells. These are all great things, but further research must be conducted before these benefits can be cemented into CBD’s repertoire.

3. There’s a CBD-Based Drug Available for Seizures: Believe it or not, the FDA itself has recognised and performed research on the effectiveness of CBD in treating certain conditions, and recently approved a drug called Epidiolex, which is formulated from CBD. This breakthrough in CBD research proves that CBD is both useful and effective in medical applications.

Epidiolex is used to treat certain severe forms of epilepsy, such as Dravet Syndrome. These rare conditions can cause debilitating and often dangerous seizures. The CBD-based drug seems to reduce the number of as well as the severity of these seizures, making life more comfortable and manageable for those suffering from these conditions.

4. CBD Is Opening New Doors In Medical Research: Besides treating epilepsy and cancer, CBD is opening doors to all kinds of new research. Studies have been conducted on the compound’s effectiveness at treating or affecting conditions such as anxiety; depression; PTSD; diabetes; heart disease; high blood pressure; skin conditions; Alzheimer’s and more.

According to the Penguin CBD team, now that CBD and hemp are officially legalised, there’s plenty of room for more research and plenty of money in the industry to support new studies. With specialised receptors for cannabinoids in our nervous systems, it’s clear that our bodies are somewhat designed to accept and make use of cannabinoids, and their incredible list of benefits only continues to grow as we learn more.

CBD has yet another useful application: helping to treat addiction. Opioid-based painkillers are the cause of thousands of overdoses and deaths each year, and yet, they’re continuously prescribed without any valid alternatives available. CBD is effective at pain management but has also been shown to reduce the symptoms of withdrawal and help reduce cravings in addicts.

5. CBD Can Be Used In Pets And Children: You probably didn’t know you could give your furry friend CBD, did you? CBD pet treats are available for pets who suffer from chronic pain, inflammation, anxiety, or even have appetite problems. They’re tasty and you’re pet won’t know that they contain anything other than that yummy steak flavour they love so much!

Pet owners all over the country are choosing CBD oil to bring their pets easy comfort and relief from conditions like arthritis. While the research on pets and CBD is scarce, millions of pet owners swear by CBD and its effectiveness.

You can also give CBD to your children. In fact, there are studies available that suggest CBD may be an effective treatment for ADHD instead of giving stimulants to your child. That’s not to say you should immediately replace your child’s ADHD medication with CBD, but you can certainly talk with your child’s doctor about this natural alternative. Many parents have found CBD to be effective at managing hyperactive children and those with focus or concentration issues.

Children also suffer from chronic pain, inflammation, and conditions such as anxiety. CBD is truly an amazing compound with a myriad of useful applications, and it spans beyond just use in adults and humans. Your pets and your children can experience its benefits as well.

CBD is only growing in popularity, and you can be sure to see some more amazing benefits discovered as more money and effort go into CBD studies. With CBD’s legal status solidified, it’s not much easier to study its effects and perform clinical trials without the threat of government interference. Where will the future of CBD and CBD products will take us? The road ahead is set to be an exciting one…

Source: https://www.we-heart.com/2020/04/13/five-things-you-didnt-know-about-cbd/

Tags: , , , ,
Posted in Hollister Biosciences | Comments Off on With greater acceptance and understanding, people know more than ever about #CBD – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

INTERVIEW: After 478% Increase In Q1 Patients, Empower Clinics $CBDT.ca Adds Telemedicine Access To Physicians and E-Commerce $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 5:30 PM on Tuesday, April 14th, 2020

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Patient visits increased 800% in February. 590% in March and 480% for Q1.  But will Coronavirus social gathering imitations put the clinic network at risk?

No.  In fact, it has had the opposite effect, with the clinics being designated an essential service.  Moreover, Empower had to actually increase operating hours due to demand from existing patients who need their CBD medication more than ever, as well as, new patients who are experiencing anxiety and stress through the COVID-19 pandemic.

BUT THAT WASN’T ENOUGH

The Company has now entered expanded into telemedicine across multiple states for patients who can’t get to a clinic but need a consultation with doctors over the phone to determine the best CBD medications, as well as, 250 new homeopath products for their newly launched immunotherapy initiative …. all which can be fulfilled through the company’s e-commerce platform.

Oh …. and did we mention that psychedelics are on the way?  Empower Clinics has already announced its intention to expand into the field of Psilocybin and psychedelics.  The new telemedicine platform now accelerates this initiative.

Watch this interview with the Company’s CEO, Steven McAuley, who is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has been able to guide Empower Clinics through the most disruptive retail environment in recent history and turn it into real growth.

Grab your favourite beverage and settle in to watch what may be your next great small cap investment

Tags: , , , , ,
Posted in AGORACOM Via Satellite, Empower Clinics Inc., Featured | Comments Off on INTERVIEW: After 478% Increase In Q1 Patients, Empower Clinics $CBDT.ca Adds Telemedicine Access To Physicians and E-Commerce $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Primo Nutraceuticals Inc. $PRMO.ca Announces New Product Website Launch to Support Brand Awareness Initiative into the Natural Health & Wellness Market $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 9:08 AM on Tuesday, April 14th, 2020
  • launched new e-commerce site that promotes brand awareness and market expansion into the natural health, wellness and hemp nutraceutical market
  • Newly designed website offers over 25 different products from 6 different brands, with insightful information on the health benefits of each product, FAQs and contact information

VANCOUVER, British Columbia, April 14, 2020 – PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce the launch of their new e-commerce site that promotes brand awareness and market expansion into the natural health, wellness and hemp nutraceutical market. The newly designed website offers over 25 different products from 6 different brands, with insightful information on the health benefits of each product, FAQs and contact information.

The company possesses proprietary formulas for cannabis edibles, topical, and tinctures with a focus on building a strong presence in the health and wellness and hemp industry with the objective of extracting and selling natural health and wellness products with and without cannabinoids (CBD) in both Canada and the United States. Brands include: PRIMO, Thrive CBD, Beauty Kitchen, Marianna Naturals, Defy and S-CELL.

The website www.primoceuticals.com will begin by offering over 25 different natural health and wellness products ranging from; Hand Sanitizers, CBD Performance drinks, Soap & Body Wash, Body & Skin Care and Hemp/CBD Oils and Gear. The website was developed in conjunction with Beauty Kitchen’s e-commerce platform to provide an easy-to-use online store for the consumer who is interested in purchasing the latest and greatest in the online natural health and wellness CBD related products. Primo has been focused on developing their new corporate and e-commerce site behind the scenes with the hopes of offering a better user experience while anticipating the increase in shareholder value. 

Andy Jagpal, President Comments:

“Our website has a clean, modern design that allows visitors to have a very informative experience with our brand as we continue to grow and increase our market presence. I encourage our shareholders to explore the website and to sign up for direct emails about new product offerings. The launch of our consumer website is a great milestone in the company’s history as we begin to offer natural health and wellness products online with and without CBD.”

About Primo Nutraceuticals

Primo Nutraceuticals Inc. (“Primo” or the “Company”) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate and farm friendly properties. Primo is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoids (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected]

To learn more about what this news means to the shareholders visit:

Shop: www.primoceuticals.com

www.twitter.com/prmonutra

www.thrivecbd.org

www.beautykitchen.net

www.drinkdefy.com

Corporate: www.primonutraceuticals.com


FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Tags: , , , , ,
Posted in Featured, PRIMO Nutraceuticals Inc. | Comments Off on Primo Nutraceuticals Inc. $PRMO.ca Announces New Product Website Launch to Support Brand Awareness Initiative into the Natural Health & Wellness Market $CROP.ca $VP.ca NF.ca $MCOA

Mota Ventures $MOTA.ca Announces Record Number of Subscriptions Year-To-Date in March and Over 6,000 New Customers in April $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 7:38 AM on Tuesday, April 14th, 2020
Mota large
  • First Class CBD and Nature’s Exclusive brands acquired over 6,000 new customers from April 1st through April 11th.
  • 1,700 of the new customers purchased products from the Immune Support line.
  • MOTA experienced a record number of new customers enrolling in a monthly subscription, totaling 18,962.

VANCOUVER, BC / ACCESSWIRE / April 14, 2020 / Mota Ventures Corp. (CSE:MOTA FSE:1WZ:GR OTC PINK:PEMTF) (the “Company“) is excited to announce its First Class CBD and Nature’s Exclusive brands acquired over 6,000 new customers from April 1st through April 11th. Additionally, during this time period over 1,700 of the new customers purchased products from the Immune Support line. During the month of March, the Company experienced a record number of new customers enrolling in a monthly subscription, totaling 18,962.

The Immunity Blend is currently the Company’s top seller in the Immune Support line. The all-natural blend is made from 100% pure essential oils, including cinnamon leaf, lemon, clove bud, lime, eucalyptus globulus, rosemary, peppermint, spearmint and oregano. The line also features Immune CBD oil containing CBD, B3, B12, Vitamin C and Zinc and Immunity Gummy Bears contain 100% natural Elderberry extract.

First Class and Nature’s Exclusive offer a CBD hemp-oil formulation intended to provide users with the therapeutic benefits that hemp may offer. The hemp oil used in the products is derived from hemp grown and cultivated in the United States. The extraction process is designed to maintain all the beneficial qualities that hemp may offer. First Class and Nature’s Exclusive offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee. The Company plans to continue its significant growth in U.S. operations over the balance of 2020, as well as an expansion into the European market.

“I am pleased at the incredible number of monthly subscriptions acquired during the month of March. We continue to see overwhelming interest in our Immune Support products and higher CBD content oils. We operate a very responsive and agile business, which allows us to identify consumer trends and execute upon the demand we are seeing in the marketplace,” stated Ryan Hoggan, CEO of the Company.

About Mota Ventures Corp.

Mota Ventures is an established eCommerce direct to consumer provider of a wide range of CBD products in the United States and Europe. In the United States, the company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its First Class CBD and Nature’s Exclusive brands. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.

Ryan Hoggan

Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Tags: , , , , , , , , , ,
Posted in All Recent Posts, Mota Ventures Corp. | Comments Off on Mota Ventures $MOTA.ca Announces Record Number of Subscriptions Year-To-Date in March and Over 6,000 New Customers in April $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Cannabis sales spike after lockdown measures in legalised areas – SPONSOR: Spyder #Cannabis $SPDR.ca – $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 12:37 PM on Monday, April 13th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

Cannabis sales spike after lockdown measures in legalised areas

  • As more people are confined to their homes, and can’t get out to unwind in other ways, they bought cannabis products at higher rates, and in bigger amounts than they have before

by Sanjana Varghese

Around the world, precautions against the spread of coronavirus have meant that people are confined to their homes for a while. Everyone has their own plans, which has included stockpiling loo roll, food and medicine. 

For people who realise that they may want to relax, those preparations include stockpiling cannabis too – in Canada, the Netherlands, and states in the US where cannabis is legal to buy, the coronavirus lockdown has caused a surge in demand for cannabis products, particularly online and at dispensaries. 

As more people are confined to their homes, and can’t get out to unwind in other ways, they bought cannabis products at higher rates, and in bigger amounts than they have before.

Now that lockdown measures have been in place for several weeks, cannabis companies and other retailers have been able to take stock of how their businesses have fared.

In the middle of March, several marijuana businesses throughout the US saw a spike in people buying all kinds of products. People also tended to be buying it in larger quantities than they would normally.

In California, sales had gone up 159 per cent compared to the sales in March of 2019. 

In general, the legal cannabis industry is a growing one, so there will be more people buying it “officially” than the year before. Even so, the kind of spike that cannabis business owners around the world saw in mid-March coincided exactly with announcements of cannabis lockdowns.  

But is this a good thing? Information from the World Health Organisation suggests that smoking cannabis can weaken the lungs, which isn’t a good thing when we have a global pandemic of a virus which attacks the respiratory system.

However, it seems people may have thought of this.

Data from Headset suggests that while sales of cannabis were up 10 per cent, edibles surged in demand too – by 28 per cent – and that people are shifting away from pre-rolled products when thinking about what they would want to stock up on for a few weeks. 

In Ontario, Canada there were almost 3,000 orders on the last Saturday before full lockdown at the Ontario Cannabis Store. That was an 80 per cent increase over a typical Saturday.  

Daffyd Roderick, the communications director at the OCS, said that they had seen a significant increase in demand for same-day and next day delivery options, in addition to a higher volume of purchases.

Other cannabis stores, in the province of Quebec, also said that they had seen a spike in sales of cannabis over the weekend. Additionally, many shops have started to operate a click and collect service – where people can come and pick up their orders themselves. These kinds of services could offer a chance for people to keep stocked up on the products they want, but they minimise social contact as much as possible. Measures like this are possible in Canada, where individual provinces maintain a monopoly on the sales of cannabis – so they can implement changes more quickly than elsewhere.

In the Netherlands, photos circulated on social media of people in towns and cities lining up to buy cannabis and weed from coffee shops before a government-imposed quarantine would put the country on lockdown. 

While cannabis is illegal in the Netherlands, it is decriminalised for personal use, and posts from social media users showed lines of more than 20 or 30 people waiting to stock up in various cities, from Amsterdam to Utrecht.

The day after the announcement was made, cafes and coffee shops were allowed to re-open as long as they were only offering takeaway services. 

The situation around cannabis in the US is different from places like Canada and the Netherlands because federal policy governs whether cannabis is legal, as well as whether there are other restrictions on what dispensaries can do with their stock. In eight states that have imposed stay-at-home orders, recreational cannabis can still be sold, and over 15 others have continued to allow the sale of medical cannabis only. 

In states like California and Washington, dispensaries have reported huge increases in demand for their products since mid March.

In Oakland, a dispensary’s whole supply was sold out by 2pm on the day that the lockdown measures were announced.

Delivery services in San Francisco said they had seen an increase in demand for cannabis delivery too, although they weren’t as severe as recent spikes. 

In Pennsylvania, Governor Tom Wolfe declared marijuana dispensaries an essential business, which brought in changes that had otherwise been passing slowly through legislation. Telemedicine – where people are prescribed medication over the phone – mean cannabis has become much more accessible, and for people who needed cannabis to treat illnesses or reduce their symptoms, getting the adequate documentation happened much more quickly too.

Some dispensaries have also transitioned to offering drive-through services too, to minimise contact. 

Other elements of the legal cannabis industry have changed in response to Covid-19. 

The government in Oregon increased the minimum amount of cannabis that you could buy in one go, to stop people from making more trips.

Websites like Leafly, which focus on the world of cannabis, have created guides on disinfecting cannabis product packaging and taking other safety precautions. For business owners, it’s an opportunity to strengthen online vendor systems and figure out whether a drive through system is possible. 

As lockdown measures are extended around the world, cannabis business owners are attempting to figure out what they should be doing next – in some cases, they ordered in extra stock and increased hours for workers. In others, they’ve been encouraging customers to place their orders online, rather than coming into town.

Currently, the length of the lockdown measures remains uncertain, so you might as well be well prepared, whether you’re buying or selling.

Source: https://www.indy100.com/article/coronavirus-cannabis-marijuana-sales-legal-lockdown-9459851

Tags: , , , , , ,
Posted in Spyder Cannabis Inc. | Comments Off on Cannabis sales spike after lockdown measures in legalised areas – SPONSOR: Spyder #Cannabis $SPDR.ca – $CGC $ACB $APH $CRON.ca $OGI.ca

Where is the #CBD Market Headed? – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 5:52 PM on Thursday, April 9th, 2020

SPONSOR: Hollister Biosciences Inc. (HOLL:CSE) A vertically integrated cannabis company with products in 220 California dispensaries and joint ventures, licensing agreement & partnerships with global brands. The company recently closed $20 MILLION deal with Venom Extracts adding $CDN 16.4 million in revenue and $CDN 2.48 million in EBITDA. Learn More

Where is the CBD Market Headed?

  • After hemp was legalized for growth and cultivation with the passing of new legislation in 2018, the CBD market erupted with new products and companies looking to take advantage of the new space
  • As of 2019, CBD sales increased by around 133%, to the tune of over $1 billion. That’s right; one billion. The market has plenty of consumer demand to back it up, and Americans are loving their CBD

By: Guest Contributor

With the last few years’ success in the CBD industry, new investors, everyday people, and seasoned investors alike are working to get their hands into one of the fastest-growing markets in the US. The CBD space is full of new providers and products, and new ones are arising each year.

As the research receives more and more funding, we’re learning all kinds of new information about CBD and its effects on the body and mind; and not much of that information is negative.

With so much demand for CBD oil and other products, it’s no surprise that people are looking to get rich by investing in the industry. But there’s still the question of whether or not it’s a good idea to invest in CBD. Let’s take a closer look at the industry, so you can decide whether or not investing in it is the right move for you.

CBD’s Benefits and Popularity

For decades, the Cannabis plant, from which CBD is derived, was outlawed, shamed, and viewed as an addictive and dangerous drug. This is mostly because THC is also derived from Cannabis, which causes the “high” that comes with smoking marijuana or ingesting THC-infused oils and edibles.

CBD is an entirely different cannabinoid, and both CBD and THC are just two of many cannabinoids found in the Cannabis plant. Each cannabinoid interacts with the body’s cannabinoid receptors in a different way, but it would take another article entirely to explain them all.

The bottom line? CBD doesn’t get you high, and industrial hemp must contain less than 0.3% THC to even be legally grown or cultivated.

CBD has been found to offer many benefits to humans and pets alike; among these are:

  • Pain relief
  • Anti-inflammatory properties
  • Counteracts the effects of THC
  • Useful in addiction recovery
  • Managing anxiety disorders and stress
  • Calming effects on the brain
  • Increase focus and concentration

The benefits of CBD products far outweigh the minor side effects, and preliminary research has yielded promising results for the future of CBD. If you want to buy CBD to give it a try, you’ve chosen the right time to start! There are hundreds of varieties available, but not all CBD is created equal.
Quality Matters in CBD

If you’re thinking of investing in the CBD space, you’ll want to put your money towards a product that exceeds others in terms of quality. The higher the quality of the CBD extract, the more potent it is.

Lower-quality extracts aren’t as effective, and if the producer is using imported hemp, you run the risk of contaminating your CBD with pesticides and other chemicals from foreign countries. The US has some strict guidelines on growing hemp, and the top providers in the industry use only organically-grown domestic hemp to extract their CBD.

The Market So Far

After hemp was legalized for growth and cultivation with the passing of new legislation in 2018, the CBD market erupted with new products and companies looking to take advantage of the new space. As of 2019, CBD sales increased by around 133%, to the tune of over $1 billion. That’s right; one billion. The market has plenty of consumer demand to back it up, and Americans are loving their CBD.

Some estimates put the market at around $20 billion by 2022, but more conservative estimates put it somewhere around half that. It’s estimated that by 2024, the market will be worth $10 billion, and that’s not something investors can ignore.

The demand for CBD products only continues to increase as the years go by, so at this point, the only way to know for sure where CBD is headed is to wait and see.

That being said, the market shows potential for growth and continues to gain traction as more and more people try and love CBD products. This makes for an excellent investment opportunity if you know what you’re doing and where to put your money.

Among specialized dispensaries, even general retailers are starting to carry CBD. You may have noticed your local grocery stores, department stores, and even convenience stores carrying CBD oil and other CBD products.

This surge in CBD availability does present an issue, however; the producers are struggling to keep up.

The Quick-Buck Types

As with any industry, there are those looking to make a quick buck by ignoring quality standards and putting out a sub-par product just to get it on the shelves and into the hands of paying customers.

With little regulation on CBD products from government agencies, the standards in the industry are generally set by the top providers, and can’t exactly be enforced.

This leads to general flooding of the market with sub-par products, and many of those “off brands” end up on store shelves as retailers try to get their hand in the CBD market. Many CBD providers are working very hard to ensure their products meet certain standards, and those are the companies you’ll want to keep your eye on.

Where To Next?

The market seems to only be headed upward as time passes. With more money for research and much less stigma surrounding CBD and cannabis, there is the potential for massive growth as the public slowly shifts its opinion on the plant itself. With projections in the billions of dollars for the future, it’s safe to say that this market has a bright future ahead of it.

Not to mention, the better we understand CBD, the better it can be marketed. We’ve already found dozens of incredible benefits for the human body, and we’re sure to find more as our understanding of CBD evolves. We just have to be patient and wait for the research!

In the meantime, the market is flourishing and is expected to flourish well into the 2020 decade. If you’re looking to invest your money in a market that can offer significant ROI and stability, CBD might just be it. Always consult with an expert first, though. You wouldn’t want to put your money into the wrong startup!

Source: https://www.bigeasymagazine.com/2020/04/06/where-is-the-cbd-market-headed/

Tags: , , , ,
Posted in All Recent Posts, Hollister Biosciences | Comments Off on Where is the #CBD Market Headed? – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

#CBD #Edibles Market to Exhibit an Astonishing CAGR of 24.30% – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 6:00 PM on Wednesday, April 8th, 2020

SPONSOR: Hollister Biosciences Inc. (HOLL:CSE) A vertically integrated cannabis company with products in 220 California dispensaries and joint ventures, licensing agreement & partnerships with global brands. The company recently closed $20 MILLION deal with Venom Extracts adding $CDN 16.4 million In revenue and $CDN 2.48 million in EBITDA. FIND OUT MORE

CBD Edibles Market to Exhibit an Astonishing CAGR of 24.30%

  • Data Bridge Market Research analyses the market to account to USD 5160 million by 2027 growing at a CAGR of 24.30% in the forecast period
  • Rising global healthcare spending is expected to enhance the market growth

By Data Bridge Market Research

The CBD Edibles Market report comprehensively studies market definition, market segmentation, competitive analysis and key developments in the market. It comprises of fundamental, secondary and advanced information related to the global status and trend, market size, sales volume, market share, growth, future trends analysis, segment and forecasts from 2020 – 2027. It includes an extensive research on the current conditions of the industry, potential of the market in the present and the future prospects from various angles. Thus, the transparent, reliable and extensive market information of this CBD Edibles report will definitely develop business and improve return on investment (ROI).

Data Bridge Market Research analyses the market to account to USD 5160 million by 2027 growing at a CAGR of 24.30% in the forecast period. Rising global healthcare spending is expected to enhance the market growth.

An Overview of the Impact of COVID-19 on Particular Market:                   

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

CBD Edibles Market Overview 2020-2027: Some of the factors such as rising production of hemp, increasing awareness about the health advantages of cannabis, rising demand from the healthcare industry, and legalization of cannabis in the various industries is expected to enhance the CBD edibles market in the forecast period of 2020 to 2027. High cost of the CBD products and presence of stringent regulations is expected to hamper the market growth in the mentioned forecast period.

Global CBD Edibles Market Scope and Market Size

CBD edibles market is segmented of the basis of source type and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

o Based on source type, the CBD edibles market is bifurcated into hemp and marijuana.

o The application segment of the CBD edibles market is segmented into personal care & cosmetics, pharmaceutical, food & beverage and others.

The Global CBD Edibles Market 2020 research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The market Report also calculate the market size, the report considers the revenue generated from the sales of This Report and technologies by various application segments. The data and the information regarding the CBD Edibles industry are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the market experts.

Global CBD Edibles Industry 2020 Market Research Report is spread across 350 pages and provides exclusive vital statistics, data, information, trends and competitive landscape details in this niche sector.

Source: https://sciencein.me/2020/04/08/cbd-edibles-market-to-exhibit-an-astonishing-cagr-of-24-30-industry-size-share-demand-growth-segmentation-and-future-insights-2020-2027/

Tags: , , , , ,
Posted in All Recent Posts, Hollister Biosciences | Comments Off on #CBD #Edibles Market to Exhibit an Astonishing CAGR of 24.30% – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Mota Ventures $MOTA.ca Acquires Interest in Folium Life Sciences $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 8:25 AM on Wednesday, April 8th, 2020
Mota large
  • Folium is a Health Canada licensed cannabis cultivator with facilities located on Vancouver Island.
  • Folium is nearing completion of the expansion of its existing cultivation facility, a further phase 2 expansion of the facility is expected.

VANCOUVER, BC / April 8, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ1)(OTCPINK:PEMTF) (the “Company“) is pleased to announce that it has acquired (the “Acquisition“) all of the outstanding share capital of 1244780 B.C. Ltd. (the “Target“). The Acquisition was completed pursuant to a share exchange agreement (the “Purchase Agreement“), dated April 7, 2020, and entered into with an arms-length third-party (the “Vendor“). The sole asset of the Target consists of a 20% equity interest in Folium Life Sciences Inc. (“Folium“), which is in the process of developing a licensed indoor cannabis production facility located on Vancouver Island. In consideration for the Acquisition, the Company has issued 21,000,000 common shares.

Folium is a Health Canada licensed cannabis cultivator with facilities located on Vancouver Island. Folium is nearing completion of the expansion of its existing cultivation facility. Its business plan calls for a further phase 2 expansion of the facility. Folium aims to produce a high quality and consistent cannabis product through its facilities.

“Canada has been a pioneer in legalization and early adoption of cannabis for both recreational and medical purposes. This equity position in a well-capitalized licensed producer provides Mota with a sound financial investment in the sector.” stated Ryan Hoggan, CEO of the Company.

Each of the Vendor, the Target, and Folium are at arms-length from the Company. The Acquisition does not constitute a fundamental change for the Company, nor has it resulted in a change of control of the Company within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. In connection with completion of the Acquisition, the Company has issued 210,000 common shares (the “Administrative Fee Shares“) to a consultant who assisted with the Acquisition.

About Mota Ventures Corp.

Mota Ventures is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Joel Shacker
President

For further information, readers are encouraged to contact Joel Shacker, President, at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Tags: , , , , , , , , , , ,
Posted in All Recent Posts, Mota Ventures Corp. | Comments Off on Mota Ventures $MOTA.ca Acquires Interest in Folium Life Sciences $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Cannabis Expo London 2020 – Experience the Europe Canna Expo SPONSOR: Mota Ventures $MOTA.ca $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 4:36 PM on Monday, April 6th, 2020

SPONSOR: Mota is seeking to become a vertically integrated global CBD brand. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota. Combined total sales of almost $29,000,000 with a EBITDA of approximately 12.5% (2019) . Click Here for More Info

Mota large

With the current climate of social distancing and uncertainty, it’s no surprise that events have been forced to cancel or postpone left, right, and centre. Despite the disruption caused by the Coronavirus pandemic, some organisers are persevering with their plans – at least for the time being. One of those events is the Europe Canna Expo, set to take place in  London in July.

The Europe Canna Expo (ECE) is scheduled to make a return to London for a 2-day event on 26-27 July. Following the success of last year’s Europe CBD expo at the same location, the ECE will aim to bring together over 90 speakers and 125 exhibitors.

The Venue

The ECE is set to make a return to the London ExCel Centre in Canning Town East London. The event was held at the venue in July 2019, with an array of exhibitors and speakers. This year, the Europe Canna Expo is expected to be even bigger. However, uncertainty remains over the event.

The ExCel Centre is currently home to the temporary Nightingale hospital – the improvised care centre for victims of the Coronavirus. It remains unclear when the need for the venue will be over as the UK’s Coronavirus lockdown continues.

Exhibitors and Speakers

However, should the expo go on as planned, attendees will be spoilt for choice with speakers and professionals set to provide insights into the CBD, cannabinoid, and medical cannabis industries. In addition, the event will be present a huge number of exhibitors including a variety of manufacturers and businesses.

Speakers will include international experts showcasing senior-level insights and global scientific research in the CBD, cannabinoid and medical cannabis sectors. Organisers of the event expect that attendees will include consumers and businesses, as well as policymakers and press.

The event will provide an opportunity for global leading brands to showcase their products to thousands of attendees. From CBD drinks and chocolates to medicinal products, the Europe Canna Expo plans to present the most innovative international brands.

Event Schedule

The ECE organisers are yet to release a detailed schedule for the two-day cannabis expo. This may be due to the ongoing uncertainty surrounding the Coronavirus lockdown. For more information and up-to-date announcements, visit the ECE London website.

https://canex.co.uk/cannabis-expo-2020-europe-canna-expo-london/

Tags: , , , , , , , , , , ,
Posted in All Recent Posts, Mota Ventures Corp. | Comments Off on Cannabis Expo London 2020 – Experience the Europe Canna Expo SPONSOR: Mota Ventures $MOTA.ca $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

« Older Entries
Newer Entries »